Koelis Announces Designated CPT I Codes for Fusion Biopsy and Transperineal Biopsy in Prostate Cancer Diagnosis
Koelis Announces Designated CPT I Codes for Fusion Biopsy and Transperineal Biopsy in Prostate Cancer Diagnosis GlobeNewswire January 07, 2026 GRENOBLE, France and PRINCETON, N.J., Jan. 07, 2026 (GLOBE NEWSWIRE) — Koelis, SAS (“Koelis” or the “Company”, www.koelis.com), a leader and innovator in MRI-ultrasound fusion guidance for prostate cancer interventions, recently announced that the Centers […]